FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892260027> ?p ?o ?g. }

• W2892260027 endingPage "503.e15" @default.
• W2892260027 startingPage "503.e9" @default.
• W2892260027 abstract "Prostate-specific antigen screening for prostate cancer (CaP) remains controversial. This study establishes the role of microRNA 301a (miR-301a) as a supplemental biomarker that can distinguish between patients with benign prostate hyperplasia and clinically significant CaP. We evaluate the ability of miR-301a to predict the adverse pathology of CaP. In the first cohort, serum and prostate tumor samples were obtained from thirteen patients with Benign prostate hyperplasia (BPH), twelve patients with Gleason 6, and sixteen patients with Gleason 7 prostate adenocarcinoma. In the second cohort, 40 prostatectomy cases were selected (BPH:12, Gleason 6:12 and Gleason 7:16). MiRNA was extracted from serum and tumor samples. Quantitative reverse transcription-polymerase chain reaction was performed for detection of miR-301a. To understand the molecular role of miR-301a, we performed cell viability, Western blots, promoter analysis, overexpression, and silencing studies in BPH and DU-145 cell lines. MiR-301a demonstrated a significantly higher expression in both serum and tumor tissue in patients with CaP when compared to patients with BPH (P = 0.011 and 0.013 for serum and tissue expression, respectively). Expression of miR-301a in prostatectomy specimens correlated with increased Gleason score. We demonstrated that miR-301a inhibited the pro-apoptotic function of RUNX3, and activated ROCK1-mediated pro-survival signal in CaP. Silencing miR-301a initiated the pro-apoptotic function of RUNX3 by inhibiting ROCK1 expression in CaP cells. Expression of miR-301a could be a valuable adjunct tool for stratifying patients with elevated prostate-specific antigen, as well as those diagnosed with CaP. Including the miR-301a as an additional variable in MSKCC post-prostatectomy nomogram improved its ability in facilitating clinical decision-making." @default.
• W2892260027 created "2018-09-27" @default.
• W2892260027 creator A5008175604 @default.
• W2892260027 creator A5013352791 @default.
• W2892260027 creator A5016900842 @default.
• W2892260027 creator A5033050122 @default.
• W2892260027 creator A5038413033 @default.
• W2892260027 creator A5057895882 @default.
• W2892260027 creator A5058310383 @default.
• W2892260027 creator A5058451695 @default.
• W2892260027 creator A5062287236 @default.
• W2892260027 creator A5069010400 @default.
• W2892260027 creator A5075673865 @default.
• W2892260027 creator A5077759533 @default.
• W2892260027 creator A5088930540 @default.
• W2892260027 date "2018-11-01" @default.
• W2892260027 modified "2023-10-18" @default.
• W2892260027 title "miR-301a expression: Diagnostic and prognostic marker for prostate cancer" @default.
• W2892260027 cites W1572102088 @default.
• W2892260027 cites W1882000757 @default.
• W2892260027 cites W1973344697 @default.
• W2892260027 cites W1980244442 @default.
• W2892260027 cites W1984516567 @default.
• W2892260027 cites W1985997519 @default.
• W2892260027 cites W1986042144 @default.
• W2892260027 cites W1991407981 @default.
• W2892260027 cites W2007902451 @default.
• W2892260027 cites W2008029604 @default.
• W2892260027 cites W2014946489 @default.
• W2892260027 cites W2020080445 @default.
• W2892260027 cites W2028898897 @default.
• W2892260027 cites W2033479946 @default.
• W2892260027 cites W2037335836 @default.
• W2892260027 cites W2038165112 @default.
• W2892260027 cites W2040153093 @default.
• W2892260027 cites W2041779667 @default.
• W2892260027 cites W2043097295 @default.
• W2892260027 cites W2047283612 @default.
• W2892260027 cites W2056122762 @default.
• W2892260027 cites W2061767895 @default.
• W2892260027 cites W2074921177 @default.
• W2892260027 cites W2077979328 @default.
• W2892260027 cites W2089001345 @default.
• W2892260027 cites W2095761465 @default.
• W2892260027 cites W2097180978 @default.
• W2892260027 cites W2100084607 @default.
• W2892260027 cites W2110966355 @default.
• W2892260027 cites W2116745900 @default.
• W2892260027 cites W2119542428 @default.
• W2892260027 cites W2133437200 @default.
• W2892260027 cites W2135926882 @default.
• W2892260027 cites W2138471534 @default.
• W2892260027 cites W2147457533 @default.
• W2892260027 cites W2165200432 @default.
• W2892260027 cites W2301645580 @default.
• W2892260027 cites W2343838362 @default.
• W2892260027 doi "https://doi.org/10.1016/j.urolonc.2018.07.014" @default.
• W2892260027 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30195463" @default.
• W2892260027 hasPublicationYear "2018" @default.
• W2892260027 type Work @default.
• W2892260027 sameAs 2892260027 @default.
• W2892260027 citedByCount "17" @default.
• W2892260027 countsByYear W28922600272019 @default.
• W2892260027 countsByYear W28922600272020 @default.
• W2892260027 countsByYear W28922600272021 @default.
• W2892260027 countsByYear W28922600272022 @default.
• W2892260027 countsByYear W28922600272023 @default.
• W2892260027 crossrefType "journal-article" @default.
• W2892260027 hasAuthorship W2892260027A5008175604 @default.
• W2892260027 hasAuthorship W2892260027A5013352791 @default.
• W2892260027 hasAuthorship W2892260027A5016900842 @default.
• W2892260027 hasAuthorship W2892260027A5033050122 @default.
• W2892260027 hasAuthorship W2892260027A5038413033 @default.
• W2892260027 hasAuthorship W2892260027A5057895882 @default.
• W2892260027 hasAuthorship W2892260027A5058310383 @default.
• W2892260027 hasAuthorship W2892260027A5058451695 @default.
• W2892260027 hasAuthorship W2892260027A5062287236 @default.
• W2892260027 hasAuthorship W2892260027A5069010400 @default.
• W2892260027 hasAuthorship W2892260027A5075673865 @default.
• W2892260027 hasAuthorship W2892260027A5077759533 @default.
• W2892260027 hasAuthorship W2892260027A5088930540 @default.
• W2892260027 hasConcept C104317684 @default.
• W2892260027 hasConcept C119056186 @default.
• W2892260027 hasConcept C121608353 @default.
• W2892260027 hasConcept C126322002 @default.
• W2892260027 hasConcept C142724271 @default.
• W2892260027 hasConcept C143998085 @default.
• W2892260027 hasConcept C145059251 @default.
• W2892260027 hasConcept C2776235491 @default.
• W2892260027 hasConcept C2777562237 @default.
• W2892260027 hasConcept C2779466945 @default.
• W2892260027 hasConcept C2780192828 @default.
• W2892260027 hasConcept C2781406297 @default.
• W2892260027 hasConcept C502942594 @default.
• W2892260027 hasConcept C55493867 @default.
• W2892260027 hasConcept C71924100 @default.
• W2892260027 hasConcept C86803240 @default.
• W2892260027 hasConcept C87874733 @default.

• next